Clinical Trial Update: Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and preliminary efficacy of combining sirolimus with bevacizumab in patients with unresectable liver cancer. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sirolimus (Sirolimus)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Liver Cancer | Phase 1 | Status: COMPLETED